MYD88 L265P mutation is seen in
Correct Answer: Waldenstrom macroglobulinemia
Description: Ans. A. Waldenstrom macroglobulinemiaExplanationMYD88L 265P is expressed in 90 to 95% of WM cases when more sensitive allele-specific PCR has been employed.Waldenstrom's macroglobulinemia (WM):It is a IgM-secreting lymphoplasmacytic lymphoma (LPL).Clinical manifestations:Cytopenia resulting from bone marrow infiltration by lymphoplasmacytic cells,Paraprotein-related cryoglobulinemia,The cold agglutinin syndrome,Demyelinating neuropathySymptomatic hyperviscosity.Oncogenic basis: not been defined.Familial clustering of Waldenstrom's macroglobulinemia and other B-cell disorders suggests that genetic factors play a role in certain patients.IgM monoclonal gammopathy of unknown significance (MGUS) is characterized by the presence of a monoclonal IgM protein and the absence of bone marrow disease involvement on histologic examination. IgM MGUS can progress to Waldenstrom's macroglobulinemia or other B-cell lymphoproliferative disordersMYD88 L265P is a commonly recurring mutation in patients with Waldenstrom's macroglobulinemia that can be useful in differentiating Waldenstrom's macroglobulinemia and non-IgM LPL from B-cell disorders that have some of the same features.
Category:
Pathology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now